The presence of antibrain antibodies in the CSF of some Alzheimer disease patients: correlation with CSF parameters
Our recent investigations demonstrated that antibodies in the cerebrospinal fluid (CSF) of some AD patients recognize cholinergic neuronal populations in the rat central nervous system (CNS). The present study correlated immunocytochemical markings produced by AD and control CSF samples in a cholinergic brain region with clinical and CSF protein parameters. There was a higher incidence of positive markings produced by AD CSF compared to control CSF. No correlation was noted with basic clinical data. However, the blood-brain barrier function was significantly correlated with immunocytochemical markings produced by AD CSF.
KeywordsMedial Septum Alzheimer Disease Patient Albumin Ratio Basic Clinical Data Immunocytochemical Marking
Unable to display preview. Download preview PDF.
- American Psychiatry Association Task Force on Nomenclature and Statistics (1980) Diagnostic and Statistical Manual of Mental Disorders (DSM-III), 3rd edn. American Psychiatry Association, Washington DCGoogle Scholar
- Blennow K, Wallin A, Fredman P, Karlsson I, Gottfries CG, Svennerholm L Blood-brain barrier disturbances in Alzheimer’s disease patients are related to vascular factors. (Submitted)Google Scholar
- Chapman J, Korczyn AD, Hareuveni M, Michaelson DM (1986) Antibodies to cholinergic cell bodies in Alzheimer’s disease. In: Fisher A, Hanin I, Lachman C (eds) Alzheimer’s and Parkinson’s diseases: strategies for research and development. Plenum Press, New York, pp 329–336Google Scholar
- Dahlstrom A, Wigander A, Lundmark K, Gottfries CG, McRae A (1990) Investigations on autoantibodies in Alzheimer’s and Parkinson’s diseases, using defined neuronal cultures. J Neural Transm [Suppl] 29: 195–206Google Scholar
- Fillit HM, Luine VN, Reisberg B, Amador R, McEwen B, Zabriskie JB (1985) Studies of the specificity of antibrain antibodies in Alzheimer’s disease. In: Hutton JT, Kenny AD (eds) Senile dementia. Alan R Liss, New York, pp 307–318Google Scholar
- Filit HM, Kemeny E, Luine V, Weksler ME, Zabriskie JB (1987) Antivascular antibodies in the sera of patients with senile dementia of the Alzheimer’s type. J Gerontol 42: 180–184Google Scholar
- Folstein M, Folstein S, McHugh P (1975) “Mini-Mental State”: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12: 189–198Google Scholar
- Lehman EL (1975) Nonparametrics. Holden Day, San FranciscoGoogle Scholar
- McKahn G, Drachman D, Folstein M, Katzman R, Price D, Stadlan E (1984) Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s disease. Neurology 34: 939–944Google Scholar
- McRae-Degueurce A, Bööj S, Haglid K, Rosengren L, Karlsson JE, Karlsson I, Wallin A, Svennerholm L, Gottfries CG, Dahlström A (1987) Antibodies in the cerebrospinal fluid of some Alzheimer patients recognize cholinergic neurons in the rat central nervous system. PNAS 84: 9214–9218PubMedCrossRefGoogle Scholar